Pamela Pavco
2017 - RXi Pharmaceuticals
In 2017, Pamela Pavco earned a total compensation of $199.9K as Former Chief Development Officer at RXi Pharmaceuticals, a 60% decrease compared to previous year.
Compensation breakdown
| Option Awards | $3,155 |
|---|---|
| Salary | $196,471 |
| Other | $228 |
| Total | $199,854 |
Pavco received $196.5K in salary, accounting for 98% of the total pay in 2017.
Pavco also received $3.2K in option awards and $228 in other compensation.
Rankings
In 2017, Pamela Pavco's compensation ranked 14,039th out of 14,666 executives tracked by ExecPay. In other words, Pavco earned more than 4.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,039 out of 14,666 | 4th |
Division Manufacturing | 5,509 out of 5,772 | 5th |
Major group Chemicals And Allied Products | 1,978 out of 2,075 | 5th |
Industry group Drugs | 1,650 out of 1,731 | 5th |
Industry Pharmaceutical Preparations | 1,264 out of 1,333 | 5th |
Source: SEC filing on April 26, 2018.
Pavco's colleagues
We found three more compensation records of executives who worked with Pamela Pavco at RXi Pharmaceuticals in 2017.